The Efficacy and Safety of Dabigatran Etexilate for the Treatment of Cerebral Venous Thrombosis
Status:
Unknown status
Trial end date:
2019-01-01
Target enrollment:
Participant gender:
Summary
This is a single-center, prospective, randomized (1:1), open-label study with two parallel
groups. This study is planned to investigate the efficacy and safety of dabigatran etexilate
comparing with warfarin for the treatment of cerebral venous thrombosis.